Aminochrome as preclinical model for Parkinson's disease

dc.creatorSegura Aguilar, Juan
dc.date.accessioned2019-01-29T14:52:19Z
dc.date.available2019-01-29T14:52:19Z
dc.date.created2019-01-29T14:52:19Z
dc.date.issued2017
dc.identifierOncotarget, Volumen 8, Issue 28, 2018, Pages 45036-45037
dc.identifier19492553
dc.identifier10.18632/oncotarget.18353
dc.identifierhttps://repositorio.uchile.cl/handle/2250/161086
dc.languageen
dc.publisherImpact Journals LLC
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceOncotarget
dc.subjectDopamine
dc.subjectDT-diaphorase
dc.subjectGlutathione transferase M2-2
dc.subjectNeurodegeneration
dc.subjectNeuromelanin
dc.titleAminochrome as preclinical model for Parkinson's disease
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución